$GEVA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SYNAGEVA BIOPHARMA CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SYNAGEVA BIOPHARMA CORP. Get notifications about new insider transactions in SYNAGEVA BIOPHARMA CORP for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Biggar Stephen R | Sell | D | 0.00 | 102 | 0 | 0 | 102 to 0 (-100.00 %) | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Option Exercise | D | 23.00 | 15,000 | 345,000 | 0 | ||
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Option Exercise | D | 40.74 | 7,500 | 305,550 | 0 | ||
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Option Exercise | D | 40.32 | 7,500 | 302,400 | 0 | ||
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Option Exercise | D | 80.35 | 7,500 | 602,625 | 0 | ||
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Option Exercise | D | 52.85 | 2,250 | 118,913 | 0 | ||
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Option Exercise | D | 33.70 | 2,250 | 75,825 | 0 | ||
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Option Exercise | D | 25.00 | 2,500 | 62,500 | 0 | ||
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Option Exercise | D | 20.60 | 2,500 | 51,500 | 0 | ||
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Option Exercise | D | 10.10 | 2,500 | 25,250 | 0 | ||
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Option Exercise | D | 11.35 | 3,000 | 34,050 | 0 | ||
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Option Exercise | D | 23.00 | 15,000 | 345,000 | 0 | ||
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Option Exercise | D | 40.74 | 7,500 | 305,550 | 0 | ||
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Option Exercise | D | 40.32 | 7,500 | 302,400 | 0 | ||
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Option Exercise | D | 80.35 | 7,500 | 602,625 | 0 | ||
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Option Exercise | D | 52.85 | 2,250 | 118,913 | 0 | ||
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Option Exercise | D | 33.70 | 2,250 | 75,825 | 0 | ||
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Option Exercise | D | 25.00 | 2,750 | 68,750 | 0 | ||
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Option Exercise | D | 20.60 | 2,750 | 56,650 | 0 | ||
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Option Exercise | D | 10.10 | 2,750 | 27,775 | 0 | ||
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Option Exercise | D | 11.35 | 3,000 | 34,050 | 0 | ||
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Sell | D | 0.00 | 9,184,771 | 0 | 0 | 9.2 M to 0 (-100.00 %) | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Sell | D | 0.00 | 12,250 | 0 | 0 | 12.3 K to 0 (-100.00 %) | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Sell | D | 0.00 | 12,250 | 0 | 0 | 12.3 K to 0 (-100.00 %) | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Sell | D | 0.00 | 680,187 | 0 | 0 | 680.2 K to 0 (-100.00 %) | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Sell | D | 0.00 | 12,250 | 0 | 0 | 12.3 K to 0 (-100.00 %) | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Sell | D | 0.00 | 12,250 | 0 | 0 | 12.3 K to 0 (-100.00 %) | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Sell | D | 0.00 | 12,250 | 0 | 0 | 12.3 K to 0 (-100.00 %) | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Sell | D | 0.00 | 143,462 | 0 | 0 | 143.5 K to 0 (-100.00 %) | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Sell | D | 0.00 | 200,526 | 0 | 0 | 200.5 K to 0 (-100.00 %) | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO, & Head of ... | Option Exercise | D | 80.35 | 45,000 | 3,615,750 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO, & Head of ... | Option Exercise | D | 40.74 | 35,000 | 1,425,900 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO, & Head of ... | Option Exercise | D | 40.32 | 45,000 | 1,814,400 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO, & Head of ... | Option Exercise | D | 23.00 | 20,497 | 471,431 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO, & Head of ... | Option Exercise | D | 1.70 | 37,228 | 63,288 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO, & Head of ... | Option Exercise | D | 0.95 | 5,982 | 5,683 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO, & Head of ... | Option Exercise | D | 0.95 | 8,964 | 8,516 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO, & Head of ... | Sell | D | 0.00 | 27,000 | 0 | 0 | 27 K to 0 (-100.00 %) |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO, & Head of ... | Sell | D | 0.00 | 5,675 | 0 | 27,000 | 32.7 K to 27 K (-17.37 %) |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO, & Head of ... | Grant | A | 78.87 | 38 | 2,997 | 32,675 | 32.6 K to 32.7 K (+0.12 %) |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 80.35 | 7,500 | 602,625 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 40.74 | 7,500 | 305,550 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 40.32 | 7,500 | 302,400 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 25.00 | 3,000 | 75,000 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 23.95 | 4,000 | 95,800 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 23.00 | 15,000 | 345,000 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 20.60 | 3,000 | 61,800 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 11.35 | 3,000 | 34,050 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Director | Option Exercise | D | 10.10 | 3,000 | 30,300 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | D | 80.35 | 120,000 | 9,642,000 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | D | 40.74 | 148,000 | 6,029,520 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | D | 40.32 | 128,000 | 5,160,960 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | D | 23.00 | 136,052 | 3,129,196 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | D | 1.70 | 22,512 | 38,270 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | D | 0.00 | 72,000 | 0 | 0 | 72 K to 0 (-100.00 %) |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | D | 0.00 | 1,031 | 0 | 72,000 | 73 K to 72 K (-1.41 %) |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | D | 0.00 | 286 | 0 | 0 | 286 to 0 (-100.00 %) |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | D | 80.35 | 7,500 | 602,625 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | D | 40.74 | 3,750 | 152,775 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | D | 40.32 | 5,001 | 201,640 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | D | 23.95 | 1,000 | 23,950 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | D | 23.00 | 8,375 | 192,625 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | D | 20.60 | 1,375 | 28,325 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | D | 11.35 | 1,500 | 17,025 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Director | Option Exercise | D | 10.10 | 1,375 | 13,888 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | TISCH THOMAS J | Director | Option Exercise | D | 80.35 | 7,500 | 602,625 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | TISCH THOMAS J | Director | Option Exercise | D | 40.74 | 15,000 | 611,100 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | TISCH THOMAS J | Director | Option Exercise | D | 40.32 | 7,500 | 302,400 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | TISCH THOMAS J | Director | Sell | D | 0.00 | 378,435 | 0 | 0 | 378.4 K to 0 (-100.00 %) |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | TISCH THOMAS J | Director | Sell | D | 0.00 | 373,560 | 0 | 0 | 373.6 K to 0 (-100.00 %) |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Bazemore Robert B | Chief Operating Off ... | Option Exercise | D | 63.11 | 50,000 | 3,155,500 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Bazemore Robert B | Chief Operating Off ... | Sell | D | 0.00 | 35,000 | 0 | 0 | 35 K to 0 (-100.00 %) |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Option Exercise | D | 80.35 | 40,000 | 3,214,000 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Option Exercise | D | 40.74 | 15,938 | 649,314 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Option Exercise | D | 40.32 | 45,000 | 1,814,400 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Option Exercise | D | 23.00 | 7,292 | 167,716 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Option Exercise | D | 1.70 | 9,929 | 16,879 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Sell | D | 0.00 | 24,000 | 0 | 0 | 24 K to 0 (-100.00 %) |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | SVP, Finance & Busi ... | Option Exercise | D | 80.35 | 12,000 | 964,200 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | SVP, Finance & Busi ... | Option Exercise | D | 40.74 | 7,500 | 305,550 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | SVP, Finance & Busi ... | Option Exercise | D | 40.32 | 12,500 | 504,000 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | SVP, Finance & Busi ... | Option Exercise | D | 23.00 | 5,000 | 115,000 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | SVP, Finance & Busi ... | Option Exercise | D | 1.70 | 838 | 1,425 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | SVP, Finance & Busi ... | Option Exercise | D | 0.95 | 82 | 78 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | SVP, Finance & Busi ... | Sell | D | 0.00 | 24,000 | 0 | 0 | 24 K to 0 (-100.00 %) |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | SVP, Finance & Busi ... | Sell | D | 0.00 | 446 | 0 | 24,000 | 24.4 K to 24 K (-1.82 %) |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | SVP, Finance & Busi ... | Grant | A | 78.87 | 56 | 4,417 | 24,446 | 24.4 K to 24.4 K (+0.23 %) |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Option Exercise | D | 80.35 | 33,750 | 2,711,813 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Option Exercise | D | 57.56 | 13,334 | 767,505 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Option Exercise | D | 40.32 | 20,002 | 806,481 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Sell | D | 0.00 | 25,500 | 0 | 0 | 25.5 K to 0 (-100.00 %) |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Sell | D | 0.00 | 524 | 0 | 25,500 | 26 K to 25.5 K (-2.01 %) |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Grant | A | 78.87 | 56 | 4,417 | 26,024 | 26 K to 26 K (+0.22 %) |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Malley Thomas | Director | Option Exercise | D | 80.35 | 7,500 | 602,625 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Malley Thomas | Director | Option Exercise | D | 40.74 | 7,500 | 305,550 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Malley Thomas | Director | Option Exercise | D | 40.32 | 7,500 | 302,400 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Malley Thomas | Director | Option Exercise | D | 23.00 | 15,000 | 345,000 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Malley Thomas | Director | Option Exercise | D | 3.52 | 51 | 180 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Malley Thomas | Director | Option Exercise | D | 0.95 | 2,149 | 2,042 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Malley Thomas | Director | Option Exercise | D | 0.95 | 5,226 | 4,965 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Malley Thomas | Director | Sell | D | 0.00 | 46,901 | 0 | 0 | 46.9 K to 0 (-100.00 %) |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | WIRTH PETER | Director | Option Exercise | D | 80.35 | 7,500 | 602,625 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | WIRTH PETER | Director | Option Exercise | D | 40.74 | 15,000 | 611,100 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | WIRTH PETER | Director | Option Exercise | D | 40.32 | 7,500 | 302,400 | 0 | |
Jun 22 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Buy | J | 0.00 | 21,196 | 0 | 100,523 | 79.3 K to 100.5 K (+26.72 %) |
Jun 22 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Sell | J | 0.00 | 211,614 | 0 | 12,250 | 223.9 K to 12.3 K (-94.53 %) |
Jun 22 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Buy | J | 0.00 | 497 | 0 | 79,327 | 78.8 K to 79.3 K (+0.63 %) |
Jun 22 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Sell | J | 0.00 | 100,490 | 0 | 12,250 | 112.7 K to 12.3 K (-89.13 %) |
Jun 22 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Buy | J | 0.00 | 40,449 | 0 | 78,830 | 38.4 K to 78.8 K (+105.39 %) |
Jun 22 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Sell | J | 0.00 | 1,068,128 | 0 | 680,187 | 1.7 M to 680.2 K (-61.09 %) |
Jun 22 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Buy | J | 0.00 | 5,543 | 0 | 38,381 | 32.8 K to 38.4 K (+16.88 %) |
Jun 22 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Sell | J | 0.00 | 55,479 | 0 | 12,250 | 67.7 K to 12.3 K (-81.91 %) |
Jun 22 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Buy | J | 0.00 | 12,500 | 0 | 32,838 | 20.3 K to 32.8 K (+61.46 %) |
Jun 22 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Sell | J | 0.00 | 165,213 | 0 | 12,250 | 177.5 K to 12.3 K (-93.10 %) |
Jun 22 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Buy | J | 0.00 | 19,318 | 0 | 20,338 | 1 K to 20.3 K (+1,893.92 %) |
Jun 22 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER JULIAN | Director | Sell | J | 0.00 | 206,800 | 0 | 12,250 | 219.1 K to 12.3 K (-94.41 %) |
Jun 22 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | J | 0.00 | 21,196 | 0 | 100,003 | 78.8 K to 100 K (+26.90 %) |
Jun 22 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Sell | J | 0.00 | 211,614 | 0 | 12,250 | 223.9 K to 12.3 K (-94.53 %) |
Jun 22 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | J | 0.00 | 497 | 0 | 78,807 | 78.3 K to 78.8 K (+0.63 %) |
Jun 22 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Sell | J | 0.00 | 100,490 | 0 | 12,250 | 112.7 K to 12.3 K (-89.13 %) |
Jun 22 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | J | 0.00 | 40,449 | 0 | 78,310 | 37.9 K to 78.3 K (+106.84 %) |
Jun 22 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Sell | J | 0.00 | 1,068,128 | 0 | 680,187 | 1.7 M to 680.2 K (-61.09 %) |
Jun 22 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | J | 0.00 | 5,543 | 0 | 37,861 | 32.3 K to 37.9 K (+17.15 %) |
Jun 22 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Sell | J | 0.00 | 55,479 | 0 | 12,250 | 67.7 K to 12.3 K (-81.91 %) |
Jun 22 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | J | 0.00 | 12,500 | 0 | 32,318 | 19.8 K to 32.3 K (+63.07 %) |
Jun 22 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Sell | J | 0.00 | 165,213 | 0 | 12,250 | 177.5 K to 12.3 K (-93.10 %) |
Jun 22 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | J | 0.00 | 19,318 | 0 | 19,818 | 500 to 19.8 K (+3,863.60 %) |
Jun 22 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Sell | J | 0.00 | 206,800 | 0 | 12,250 | 219.1 K to 12.3 K (-94.41 %) |
Jun 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Grant | A | 0.00 | 24,000 | 0 | 24,000 | 0 to 24 K |
Jun 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | SVP, Finance & Busi ... | Grant | A | 0.00 | 24,000 | 0 | 24,390 | 390 to 24.4 K (+6,153.85 %) |
Jun 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Grant | A | 0.00 | 72,000 | 0 | 73,031 | 1 K to 73 K (+6,983.51 %) |
Jun 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Bazemore Robert B | Chief Operating Off ... | Grant | A | 0.00 | 5,000 | 0 | 35,000 | 30 K to 35 K (+16.67 %) |
Jun 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Option Exercise | M | 80.35 | 11,250 | 903,938 | 33,750 | |
Jun 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Option Exercise | M | 57.56 | 833 | 47,947 | 13,334 | |
Jun 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Option Exercise | M | 40.32 | 833 | 33,587 | 20,002 | |
Jun 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Sell | S | 215.72 | 2,520 | 543,614 | 25,968 | 28.5 K to 26 K (-8.85 %) |
Jun 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Sell | S | 214.72 | 10,396 | 2,232,229 | 28,488 | 38.9 K to 28.5 K (-26.74 %) |
Jun 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Buy | M | 80.35 | 11,250 | 903,938 | 38,884 | 27.6 K to 38.9 K (+40.71 %) |
Jun 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Buy | M | 57.56 | 833 | 47,947 | 27,634 | 26.8 K to 27.6 K (+3.11 %) |
Jun 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Buy | M | 40.32 | 833 | 33,587 | 26,801 | 26 K to 26.8 K (+3.21 %) |
Jun 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Grant | A | 0.00 | 25,500 | 0 | 25,968 | 468 to 26 K (+5,448.72 %) |
Jun 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO, & Head of ... | Grant | A | 0.00 | 27,000 | 0 | 32,637 | 5.6 K to 32.6 K (+478.98 %) |
May 08 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Option Exercise | M | 57.56 | 833 | 47,947 | 14,167 | |
May 08 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Option Exercise | M | 40.32 | 833 | 33,587 | 20,835 | |
May 08 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Sell | S | 215.26 | 100 | 21,526 | 468 | 568 to 468 (-17.61 %) |
May 08 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Sell | S | 206.97 | 100 | 20,697 | 568 | 668 to 568 (-14.97 %) |
May 08 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Sell | S | 206.27 | 400 | 82,508 | 668 | 1.1 K to 668 (-37.45 %) |
May 08 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Sell | S | 204.94 | 400 | 81,976 | 1,068 | 1.5 K to 1.1 K (-27.25 %) |
May 08 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Sell | S | 203.99 | 666 | 135,857 | 1,468 | 2.1 K to 1.5 K (-31.21 %) |
May 08 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Buy | M | 57.56 | 833 | 47,947 | 2,134 | 1.3 K to 2.1 K (+64.03 %) |